Corporation Presentations
Recent Events
November 2022- SITC 2022
May 2022- Adenosine-Pathway Targeted Cancer Immunotherapy Summit
【BP1200,BP1202】 Targeted Inhibition of Adenosine Pathway by Humanized Antibodies to Enhance the Cancer Immunity
【BP1200,BP1202】 Targeted Inhibition of Adenosine Pathway by Humanized Antibodies to Enhance the Cancer Immunity